Peptides

Tirzepatide: The Ultimate Guide for Weight Loss

Dosage calculator available

Reconstitution & dosing math for Tirzepatide.

Tirzepatide is a groundbreaking "twincretin" medication that activates both GIP and GLP-1 receptors, producing dramatic weight loss (15-25% of body weight) and superior blood sugar control. It was approved by the FDA in May 2022 and is given as a once-weekly injection.

The Five-Pronged Mechanism

Enhanced insulin production (glucose-dependent)
Appetite suppression
Gastric emptying modulation
Insulin sensitivity restoration
Metabolic rate enhancement

The Smart Dosing Protocol

Standard titration — subcutaneous, once weekly.

Weeks	Weekly Dose
Weeks 1–4	2.5 mg
Weeks 5–8	5 mg
Weeks 9–12	7.5 mg
Weeks 13–16	10 mg
Weeks 17+	12.5–15 mg

Dosing Notes

Many find the sweet spot at 10-15 mg weekly. A sensitive-start option uses 1.25 mg for the first two weeks.

Real-World Results

Reconstructed from the outcome values stated in the source.

Outcome	Result
Weight loss	16–22%
HbA1c reduction	2.0–2.4%
Blood pressure	−7 to −10 mmHg
LDL cholesterol	−4 to −10%
Triglycerides	−15 to −25%

Managing Side Effects

Reconstructed from the frequency values stated in the source.

Side Effect	Frequency
Nausea	15–40%
Diarrhea	10–20%
Constipation	5–10%
Vomiting	<5%
Pancreatitis	<0.2%

Clinical Data

In the SURMOUNT-1 trial, 50-60% of participants lost at least 15% of body weight. In a head-to-head comparison against semaglutide, tirzepatide reduced HbA1c by 2.4% vs 1.9%.

This profile is being expanded — additional sections from the source are still being added.

Related in the library